首页> 美国卫生研究院文献>Cancer Medicine >Diagnostic value of CA‐153 and CYFRA 21‐1 in predicting intraocular metastasis in patients with metastatic lung cancer
【2h】

Diagnostic value of CA‐153 and CYFRA 21‐1 in predicting intraocular metastasis in patients with metastatic lung cancer

机译:CA-153和CYFRA 21-1在预测转移性肺癌患者眼内转移中的诊断价值

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Lung cancer is prone to metastasis to various organs. Although intraocular metastasis (IOM) occurs at a later stage than metastasis to other organs, it often adversely affects the quality of life and suggests a poor prognosis. In this study, we selected 1608 patients with lung cancer who had metastasis to at least one site and explored clinical differences between those with IOM and non‐IOM (NIOM). An independent test and chi‐squared test were used to analyze the clinical features of the patients. The statistically significant parameters were analyzed by binary logistic regression to determine the risk factors for IOM. A receiver operating characteristic curve was constructed to assess their diagnostic value in IOM. The results showed that no significant differences were noted in age, gender, and pathological type between the IOM and NIOM groups. However, the IOM group had higher levels of alpha‐fetoprotein, carcinoembryonic antigen, cancer antigen (CA)‐125, CA‐153, cytokeratin fragment 19 (CYFRA 21‐1), and total prostate‐specific antigen, compared with the NIOM group. Binary logistic regression indicated that CA‐153 and CYFRA 21‐1 were risk factors for IOM in patients with MLC (
机译:肺癌易于转移到各个器官。尽管眼内转移发生在比其他器官转移晚的阶段,但它通常会对生活质量产生不利影响,并提示预后不良。在这项研究中,我们选择了1608例转移至至少一个部位的肺癌患者,并探讨了IOM和非IOM(NIOM)患者之间的临床差异。使用独立检验和卡方检验来分析患者的临床特征。通过二元logistic回归分析统计上重要的参数,以确定IOM的危险因素。构建接收器工作特性曲线以评估其在IOM中的诊断价值。结果显示,IOM组和NIOM组之间在年龄,性别和病理类型方面没有显着差异。但是,与NIOM组相比,IOM组的甲胎蛋白,癌胚抗原,癌抗原(CA)-125,CA-153,细胞角蛋白片段19(CYFRA 21-1)和总前列腺特异性抗原水平更高。二元逻辑回归分析表明,CA‐153和CYFRA 21-1是MLC患者IOM的危险因素(

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号